BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21285110)

  • 1. Health outcomes in economic evaluation: who should value health?
    Stamuli E
    Br Med Bull; 2011; 97():197-210. PubMed ID: 21285110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis in severe mental illness: outcome measures selection.
    Stant AD; Buskens E; Jenner JA; Wiersma D; TenVergert EM
    J Ment Health Policy Econ; 2007 Jun; 10(2):101-8. PubMed ID: 17603150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodological issues raised by preference-based approaches to measuring the health status of children.
    Petrou S
    Health Econ; 2003 Aug; 12(8):697-702. PubMed ID: 12898666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferences for health outcomes and cost-utility analysis.
    Torrance GW
    Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valuing the health state 'tinnitus': differences between patients and the general public.
    Happich M; von Lengerke T
    Hear Res; 2005 Sep; 207(1-2):50-8. PubMed ID: 15919164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A social preference valuations set for EQ-5D health states in Flanders, Belgium.
    Cleemput I
    Eur J Health Econ; 2010 Apr; 11(2):205-13. PubMed ID: 19582490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life-saving treatments and disabilities. Are all QALYs created equal?
    Ubel PA; Richardson J; Prades JL
    Int J Technol Assess Health Care; 1999; 15(4):738-48. PubMed ID: 10645115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic value of out-of-hospital emergency care: a structured literature review.
    Lerner EB; Maio RF; Garrison HG; Spaite DW; Nichol G
    Ann Emerg Med; 2006 Jun; 47(6):515-24. PubMed ID: 16713777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness to pay in the context of an economic evaluation of healthcare programs: theory and practice.
    Gafni A
    Am J Manag Care; 1997 May; 3 Suppl():S21-32. PubMed ID: 10180338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Health status indicators: features of the economic approach].
    Ghislandi S; Bertolini G; Garattini L
    Epidemiol Prev; 2000; 24(6):262-9. PubMed ID: 11219203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferences and person trade-offs: forcing consistency or inconsistency in health-related quality of life measures?
    Mansley EC; Elbasha EH
    Health Econ; 2003 Mar; 12(3):187-98. PubMed ID: 12605464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elicitation of informed general population health state utility values: a review of the literature.
    McTaggart-Cowan H
    Value Health; 2011 Dec; 14(8):1153-7. PubMed ID: 22152187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A note on the nature of utility in time and health and implications for cost utility analysis.
    Buckingham KJ; Devlin NJ
    Soc Sci Med; 2009 Jan; 68(2):362-7. PubMed ID: 19019518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of health economic decisions in actual practice: the role of behavioral economics. Summary of the presentation given by Professor Daniel Kahneman at the ISPOR 10th Annual International Meeting First Plenary Session, May 16, 2005, Washington, DC, USA.
    Value Health; 2006; 9(2):65-7. PubMed ID: 16626409
    [No Abstract]   [Full Text] [Related]  

  • 19. Valuing quality of life: results for New Zealand health professionals.
    Devlin N; Williams A
    N Z Med J; 1999 Mar; 112(1083):68-71. PubMed ID: 10210306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.